Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Volumn 13, Issue 1, 2011, Pages

  Leyva, Francisco ^a   Foley, Paul W X ^a   Chalil, Shajil ^a   Ratib, Karim ^a   Smith, Russell E A ^a   Prinzen, Frits ^b   Auricchio, Angelo ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c DIVISION OF CARDIOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOLINIUM PENTETATE; LOOP DIURETIC AGENT; SPIRONOLACTONE;

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CONTRAST ENHANCEMENT; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART DEATH; HEART FAILURE; HOSPITALIZATION; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CHI SQUARE DISTRIBUTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART VENTRICLE REMODELING; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH; TIME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; DEATH, SUDDEN, CARDIAC; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; MIDDLE AGED; MYOCARDIUM; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 80053491332     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-13-29     Document Type: Article

References (35)

1. for the Cardiac Resynchronization-Heart Failure (CARE-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, N Eng J Med 2005 352 1539 1549 10.1056/NEJMoa050496 (Pubitemid 40517094)
2. for the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced heart failure. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass D, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, et al. N Eng J Med 2004 350 2140 2150 10.1056/NEJMoa032423 (Pubitemid 38637994)
3. Effects of multisite biventricular pacing in patients with heart failure and interventricular conduction delay. Cazeau S, Leclercq C, Lavergene T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, et al. N Engl J Med 2001 344 873 880 10.1056/NEJM200103223441202 11259720 (Pubitemid 32224395)
4. Cardiac resynchronization in chronic heart failure. Abraham WT, Fisher WG, Smith AL, Deluergio DB, Leon AR, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, et al. N Engl J Med 2002 346 24 1845 1853 10.1056/NEJMoa013168 12063368 (Pubitemid 34603028)
5. Effectiveness of resynchronization therapy in patients with end-stage heart failure. Molhoek SG, Bax JJ, van Erven L, Bootsma M, Boersma E, Steendijk P, Van der Wall EE, Schalij MJ, Am J Cardiol 2002 92 1238 1240
6. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Chalil S, Foley P, Muyhaldeen S, Patel K, Yousef Z, Smith R, Frenneaux M, Leyva F, Europace 2007 9 1031 1037 10.1093/europace/eum133 17933857 (Pubitemid 351773274)
7. Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy. Chalil S, Stegemann B, Muhyaldeen S, Khadjooi S, Foley P, Smith R, Leyva F, Pacing Clin Electrophysiol 2007 10 1201 1207
8. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Adelstein EC, Saba S, Am Heart J 2007 153 1 105 112 10.1016/j.ahj.2006.10.015 17174647 (Pubitemid 44880886)
9. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Alpert JS, Thygesen K, Antman E, Bassand JP, J Am Coll Cardiol 2000 36 959 969 10.1016/S0735-1097(00)00804-4 10987628
10. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, Sheppard MN, Poole-Wilson PA, Pennell DJ, J Am Coll Cardiol 2006 48 10 1977 1985 10.1016/j.jacc.2006.07.049 17112987 (Pubitemid 44738448)
11. Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance. Barnett D, Phillips S, Longson C, Heart 2007 93 1134 1135 10.1136/hrt.2007.127563 17699177 (Pubitemid 47310998)
12. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Guyatt GH, Sullivan MJ, Thompson PJ, Can Med Assoc J 1985 132 919 923 3978515
13. Determination of the optimal atrioventricular delay in DDD pacing: Comparison between echo and peak endocardial acceleration measurements. Ritter P, Padeletti L, Gillio-Meina L, Gaggini G, Europace 1999 1 126 130 10.1053/eupc.1998.0032 11228855
14. Cardiac arrest and sudden cardiac death. Myerburg RJ, Castellanos A, Heart disease: a textbook of cardiovascular medicine New York: WB Saunders Publishing Co, Braunwald E, 1997 742 779
15. Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. Rockman HA, Juneau C, Chatterjee K, Rouleau JL, Am J Cardiol 1989 64 19 1344 1348 10.1016/0002- 9149(89)90579-1 2589201 (Pubitemid 20000087)
16. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE, J Am Coll Cardiol 2002 39 1151 1158 10.1016/S0735-1097(02)01726-6 11923039 (Pubitemid 34267418)
17. Visualisation of presence, location and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kin RJ, Lancet 2001 357 21 28 10.1016/S0140-6736(00)03567-4 11197356 (Pubitemid 32056497)
18. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. Kim RJ, Wu E, Rafael A, Chen E-L, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM, N Engl J Med 2000 343 1445 1453 10.1056/NEJM200011163432003 11078769
19. Gadolinium cardiovascular magnetic resonance predicts myocardial dysfunction and remodelling in patients with heart failure undergoing beta-blocker therapy. Bello D, Shah DJ, Farah GM, Di Luzio S, Parker MA, Johnson M, Cotts WG, Klocke FJ, Bonow RO, Judd RM, et al. Circulation 2003 108 1945 1953 10.1161/01.CIR.0000095029.57483.60 14557364 (Pubitemid 37296539)
20. Electrical impedance properties of normal and chronically infarcted ventricular myocardium. Schwartzman D, Chang I, Michele JJ, Moritznik MS, Foster KR, J Interv Card Electrophysiol 1999 3 213 224 10.1023/A:1009887306055 10490477
21. Combined Epicardial and Endocardial Electroanatomic Mapping in a Porcine Model of Healed Myocardial Infarction. Reddy VY, Wrobleski D, Houghtaling C, Josephson ME, Ruskin JN, Circulation 2003 107 25 3236 3242 10.1161/01.CIR. 0000074280.62478.E1 12796129 (Pubitemid 36793097)
22. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Bleeker GB, Kaandorp TAM, Lamb HJ, Boersma E, Steendijk P, de Roos A, vdW EE, Schalij MJ, Bax JJ, Circulation 2006 113 969 976 10.1161/CIRCULATIONAHA.105.543678 16476852 (Pubitemid 43879472)
23. Feasibility of adjusting paced left ventricular activation by manipulating stimulus strength. Tedrow U, Maisel W, Epstein L, Soejima K, Stevenson W, J Am Coll Cardiol 2004 44 2249 2251 10.1016/j.jacc.2004.09.008 15582325 (Pubitemid 39576047)
24. Echocardiographic quantification of left ventricular asynchrony predicts an acute hemodynamic benefit of cardiac resynchronization therapy. Breithardt OA, Stellbrink C, Kramer AP, Sinha AM, Franke A, Salo R, Schiffgens B, Huvelle E, Auricchio A, PATH-CHF Study Group, J Am Coll Cardiol 2002 40 536 545 10.1016/S0735-1097(02)01987-3 12142123 (Pubitemid 34833172)
25. Left ventricular pacing minimizes diastolic ventricular interaction, allowing improved preload-dependent systolic performance. Bleasdale RA, Turner MS, Mumford CE, Steendijk P, Paul V, Tyberg JV, Morris-Thurgood JA, Frenneaux MP, Circulation 2004 110 16 2395 2400 10.1161/01.CIR.0000145169.82004.CF 15477415 (Pubitemid 39407345)
26. Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. Ypenburg C, Lancellotti P, Tops LF, Bleeker GB, Holman ER, Pierard LA, Schalij MJ, Bax JJ, J Am Coll Cardiol 2007 50 21 2071 2077 10.1016/j.jacc.2007.08.019 18021876 (Pubitemid 350087580)
27. Echocardiographic evaluation of mitral geometry in functional mitral regurgitation. Sadeghpour A, Abtahi F, Kiavar M, Esmaeilzadeh M, Samiei N, Ojaghi SZ, Bakhshandeh H, Maleki M, Noohi F, Mohebbi A, Journal of cardiothoracic surgery 2008 3 54 10.1186/1749-8090-3-54 18840276
28. Short-Term Hemodynamic Effects of Cardiac Resynchronization Therapy in Patients With Heart Failure, a Narrow QRS Duration, and No Dyssynchrony. Williams LK, Ellery S, Patel K, Leyva F, Bleasdale RA, Phan TT, Stegemann B, Paul V, Steendijk P, Frenneaux M, Circulation 2009 108 799395 CIRCULATIONAHA
29. Re-entrant ventricular arrhythmias in the late myocardial infarction period. 2. Patterns of initiation and termination of re-entry. El-Sherif N, Hope RR, Scherlag BJ, Lazzara R, Circulation 1977 55 5 702 719 849630 (Pubitemid 8090084)
30. Re-entrant ventricular arrhythmias in the late myocardial infarction period. 1. Conduction characteristics in the infarction zone. El-Sherif N, Scherlag BJ, Lazzara R, Hope RR, Circulation 1977 55 5 686 702 849629 (Pubitemid 8090083)
31. Reentrant ventricular arrhythmias in the late myocardial infarction period. 9. Electrophysiologic-anatomic correlation of reentrant circuits. Mehra R, Zeiler RH, Gough WB, El-Sherif N, Circulation 1983 67 1 11 24 6183020 (Pubitemid 13222065)
32. Identifying patients at risk of sudden death after myocardial infarction: value of the response to programmed stimulation, degree of ventricular ectopic activity and severity of left ventricular dysfunction. Marchlinski FE, Buxton AE, Waxman HL, Josephson ME, Am J Cardiol 1983 52 10 1190 1196 10.1016/0002-9149(83)90572-6 6650407 (Pubitemid 14243971)
33. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marban E, Tomaselli GF, et al. Circulation 2007 115 15 2006 2014 10.1161/CIRCULATIONAHA.106.653568 17389270 (Pubitemid 46625951)
34. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, et al. Circ Cardiovasc Imaging 2009 2 3 183 190 19808591
35. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council of the American Heart Association. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, Circulation 2002 105 539 542 10.1161/hc0402.102975 11815441 (Pubitemid 34262671)